Work

Erratum

Year: 2021

Type: erratum

Abstract: In the published article titled “Osimertinib in non-small cell lung cancer: real world data from New Zealand,” JTO Clin Res Rep. 2020;1:100022, the authors wish to add the following disclosure statement:

Source: JTO Clinical and Research Reports

DOI: 10.1016/j.jtocrr.2021.100168

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,000

OpenAlex ID: W4231573407

Cites:

Cited by:

Related to: 10